Navigation Links
Diabetics to get Relief from Cheaper Drugs

The Federal Government’s decision to list two new drugs on the Pharmaceutical Benefits Scheme will allow diabetics to have better access to treatment from October.//

According to Health Minister Tony Abbott long-lasting injectable insulins Levemir and Lantus will be subsidized from October 1, at a cost of $145 million over the next three years.

These drugs have several medical advantages over current subsidized treatments.

Daily injections are needed by all type-one diabetics and some type-two diabetics to control their blood sugar levels.

Presently about 210,000 Australians with type one and type two diabetes will qualify for the drugs, and about 110,000 people are expected to use them in the first year of listing.

By 2009 about 160,000 patients are expected to benefit from this with each paying $9.40 for concession card holders and non-concessional patients paying about $59 for a year's supply.

According to Donald Chisholm, professor of endocrinology at Sydney's St Vincent's Hospital, these drugs could help to bring down the number of injections for some patients because of the longer lasting effect compared to other common insulin.

Prof Chisholm said that these drugs are absorbed slowly during the 24 hours after an injection, thereby preventing a potentially dangerous peak in insulin levels as well as lowering the risk of hypoglycaemia
'"/>




Page: 1

Related medicine news :

1. Cinnamon May Help Diabetics
2. Heart disease threat starts early in life for Diabetics
3. Diabetics and their babies
4. Beta-Carotene May Aid Diabetics
5. Diabetics prone to periodontitis
6. Blood Vessel Surgery Safe for Diabetics
7. Marriage does good for Diabetics
8. Niacin Safe for Diabetics
9. Diabetics & Foot infections
10. Diabetics Need to Guard Against Nail Fungus
11. Pancreas Transplant for Diabetics
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: